Saw Palmetto "Moderate" Quality Evidence Shows BPH Symptom Relief - USP
This article was originally published in The Tan Sheet
The U.S. Pharmacopeia's final monograph on saw palmetto lists 10 published studies on the ingredient that met the USP quality standard of Level II or higher, under the organization's new criteria for evidence submission for botanicals.
You may also be interested in...
The U.S. Pharmacopeia will discuss standard-setting issues related to the supplement ingredient ephedra during an internal meeting July 17
The U.S. Pharmacopeia has released National Formulary preview monographs for docosahexaenoic acid, DHA oil and DHA capsules; the monographs appear in the November-December Pharmacopeial Forum.
Only eight of 13 saw palmetto supplements tested by Consumer Reports contain an adequate amount of the extract, the magazine reports in its September issue.